Commentary Open Access Logo

Significance of Sialoglycans in SARS-CoV2 Infection

Saravanakarthikeyan Balasubramanian 1, * ORCID logo
Divya Vinayachandran 2 ORCID logo
  1. Conservative Dentistry and Endodontics, SRM Dental College, Ramapuram, SRM Institute of Science and Technology, Chennai- 600 089, Tamil Nadu, India
  2. Oral Medicine and Radiology, SRM Kattankulathur Dental College and Hospitals, SRM Institute of Science and Technology, Chennai- 603 203, Tamil Nadu, India
Correspondence to: Saravanakarthikeyan Balasubramanian, Conservative Dentistry and Endodontics, SRM Dental College, Ramapuram, SRM Institute of Science and Technology, Chennai- 600 089, Tamil Nadu, India. ORCID: https://orcid.org/0000-0003-1850-3581. Email: [email protected].
Volume & Issue: Vol. 8 No. 10 (2021) | Page No.: 4612-4613 | DOI: 10.15419/bmrat.v8i10.696
Published: 2021-10-09

Online metrics


Statistics from the website

  • HTML Views: 5694
  • PDF Views: 1932
  • XML Views: 2

Statistics from Dimensions

This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

The second wave of coronavirus disease 19 (COVID-19) has hit India badly with a rapid surge of cases. One of the greatest challenges in managing infections from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the incomplete knowledge regarding the disease course, hypersensitivity, and relative resistance in a number of individuals. Recently, it has been reported that besides the Angiotensin-converting enzyme 2 (ACE2), certain sialic acids present on the cell surface may also function as potential receptors for binding the spike protein of SARS-CoV-2. In this brief commentary we briefly discuss the role of sialic acids in SARS-CoV-2 infection and suggest more research investigations pertaining to this arena. This may pave the way for breakthrough solutions to combat the current pandemic more effectively by developing specific drug-targeted therapies.

Sorry, we can not display full-text of this article in HTML format for you right now. Please get the article in PDF format instead.

Comments